Which has stronger valuation and earnings, INGN or NSPR?

InspireMD has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inogen $348.67M 0.47 -$22.75M -$0.91 N/A InspireMD $10.85M 4.30 -$19.92M -$0.73 N/A

Is INGN or NSPR more profitable?

Inogen has a net margin of -7.08% compared to InspireMD's net margin of -413.96%. Inogen's return on equity of -12.90% beat InspireMD's return on equity. Company Net Margins Return on Equity Return on Assets Inogen -7.08% -12.90% -8.27% InspireMD -413.96% -69.42% -57.68%

Does the media favor INGN or NSPR?

In the previous week, Inogen and Inogen both had 4 articles in the media. Inogen's average media sentiment score of 0.93 beat InspireMD's score of 0.72 indicating that Inogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InspireMD 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, APYX or NSPR?

Apyx Medical has higher revenue and earnings than InspireMD. Apyx Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apyx Medical $52.84M 3.01 -$11.21M -$0.22 N/A InspireMD $10.85M 4.30 -$19.92M -$0.73 N/A

Is APYX or NSPR more profitable?

Apyx Medical has a net margin of -16.40% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -16.40% -88.47% -14.94% InspireMD -413.96% -69.42% -57.68%

Does the media favor APYX or NSPR?

In the previous week, InspireMD had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for InspireMD and 2 mentions for Apyx Medical. InspireMD's average media sentiment score of 0.72 beat Apyx Medical's score of 0.54 indicating that InspireMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive InspireMD 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, NSPR or CVRX?

InspireMD has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.85M 4.30 -$19.92M -$0.73 N/A CVRx $59.07M 2.40 -$53.31M -$2.02 N/A

Is NSPR or CVRX more profitable?

CVRx has a net margin of -89.14% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% CVRx -89.14% -120.76% -48.38%

Does the media prefer NSPR or CVRX?

In the previous week, InspireMD had 2 more articles in the media than CVRx. MarketBeat recorded 4 mentions for InspireMD and 2 mentions for CVRx. CVRx's average media sentiment score of 0.93 beat InspireMD's score of 0.72 indicating that CVRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NSPR or ?

InspireMD presently has a consensus price target of $4.50, indicating a potential upside of 352.26%. Given InspireMD's stronger consensus rating and higher probable upside, research analysts clearly believe InspireMD is more favorable than . Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, NSPR or ?

has lower revenue, but higher earnings than InspireMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.85M 4.30 -$19.92M -$0.73 N/A N/A N/A N/A N/A N/A

Is NSPR or more profitable?

has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. 's return on equity of 0.00% beat InspireMD's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% N/A N/A N/A

Does the media favor NSPR or ?

In the previous week, had 1396 more articles in the media than InspireMD. MarketBeat recorded 1400 mentions for and 4 mentions for InspireMD. InspireMD's average media sentiment score of 0.72 beat 's score of 0.00 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 415 Very Positive mention(s) 298 Positive mention(s) 316 Neutral mention(s) 212 Negative mention(s) 159 Very Negative mention(s) Neutral

Is HYPR or NSPR more profitable?

Hyperfine has a net margin of -226.88% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Hyperfine's return on equity. Company Net Margins Return on Equity Return on Assets Hyperfine -226.88% -98.83% -67.09% InspireMD -413.96% -69.42% -57.68%

InspireMD (NSPR) Competitors

$1.00 -0.02 (-1.49%)

As of 02:04 PM Eastern

Compare

NSPR vs. INGN, APYX, CVRX, EDAP, and HYPR

Should you buy InspireMD stock or one of its competitors? MarketBeat compares InspireMD with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with InspireMD include Inogen (INGN), Apyx Medical (APYX), CVRx (CVRX), Edap Tms (EDAP), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

How does InspireMD compare to Inogen?

Inogen (NASDAQ:INGN) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

In the previous week, Inogen and Inogen both had 4 articles in the media. Inogen's average media sentiment score of 0.93 beat InspireMD's score of 0.72 indicating that Inogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InspireMD	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Inogen has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

89.9% of Inogen shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 29.7% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

InspireMD has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.47	-$22.75M	-$0.91	N/A
InspireMD	$10.85M	4.30	-$19.92M	-$0.73	N/A

Inogen presently has a consensus price target of $14.00, indicating a potential upside of 132.83%. InspireMD has a consensus price target of $4.50, indicating a potential upside of 352.26%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Inogen has a net margin of -7.08% compared to InspireMD's net margin of -413.96%. Inogen's return on equity of -12.90% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-7.08%	-12.90%	-8.27%
InspireMD	-413.96%	-69.42%	-57.68%

Summary

Inogen and InspireMD tied by winning 8 of the 16 factors compared between the two stocks.

How does InspireMD compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

In the previous week, InspireMD had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for InspireMD and 2 mentions for Apyx Medical. InspireMD's average media sentiment score of 0.72 beat Apyx Medical's score of 0.54 indicating that InspireMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
InspireMD	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical has higher revenue and earnings than InspireMD. Apyx Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.01	-$11.21M	-$0.22	N/A
InspireMD	$10.85M	4.30	-$19.92M	-$0.73	N/A

Apyx Medical presently has a consensus target price of $6.50, indicating a potential upside of 71.28%. InspireMD has a consensus target price of $4.50, indicating a potential upside of 352.26%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by company insiders. Comparatively, 29.7% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Apyx Medical has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

Apyx Medical has a net margin of -16.40% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
InspireMD	-413.96%	-69.42%	-57.68%

Summary

Apyx Medical and InspireMD tied by winning 8 of the 16 factors compared between the two stocks.

How does InspireMD compare to CVRx?

InspireMD (NYSE:NSPR) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

InspireMD currently has a consensus target price of $4.50, indicating a potential upside of 352.26%. CVRx has a consensus target price of $11.50, indicating a potential upside of 115.56%. Given InspireMD's higher possible upside, equities research analysts plainly believe InspireMD is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

In the previous week, InspireMD had 2 more articles in the media than CVRx. MarketBeat recorded 4 mentions for InspireMD and 2 mentions for CVRx. CVRx's average media sentiment score of 0.93 beat InspireMD's score of 0.72 indicating that CVRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

44.8% of InspireMD shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 29.7% of InspireMD shares are held by insiders. Comparatively, 18.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

InspireMD has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	4.30	-$19.92M	-$0.73	N/A
CVRx	$59.07M	2.40	-$53.31M	-$2.02	N/A

InspireMD has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, CVRx has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

CVRx has a net margin of -89.14% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
CVRx	-89.14%	-120.76%	-48.38%

Summary

InspireMD beats CVRx on 9 of the 16 factors compared between the two stocks.

How does InspireMD compare to ?

InspireMD (NYSE:NSPR) and (:) are related companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. 's return on equity of 0.00% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
	N/A	N/A	N/A

In the previous week, had 1396 more articles in the media than InspireMD. MarketBeat recorded 1400 mentions for and 4 mentions for InspireMD. InspireMD's average media sentiment score of 0.72 beat 's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
	415 Very Positive mention(s)	298 Positive mention(s)	316 Neutral mention(s)	212 Negative mention(s)	159 Very Negative mention(s)	Neutral

InspireMD presently has a consensus price target of $4.50, indicating a potential upside of 352.26%. Given InspireMD's stronger consensus rating and higher probable upside, research analysts clearly believe InspireMD is more favorable than .

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

has lower revenue, but higher earnings than InspireMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	4.30	-$19.92M	-$0.73	N/A
	N/A	N/A	N/A	N/A	N/A

44.8% of InspireMD shares are held by institutional investors. 29.7% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

InspireMD beats on 7 of the 11 factors compared between the two stocks.

How does InspireMD compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Hyperfine has a net margin of -226.88% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Hyperfine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperfine	-226.88%	-98.83%	-67.09%
InspireMD	-413.96%	-69.42%	-57.68%

In the previous week, Hyperfine and Hyperfine both had 4 articles in the media. InspireMD's average media sentiment score of 0.72 beat Hyperfine's score of 0.15 indicating that InspireMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Hyperfine	Neutral
InspireMD	Positive

Hyperfine presently has a consensus target price of $1.78, indicating a potential upside of 20.90%. InspireMD has a consensus target price of $4.50, indicating a potential upside of 352.26%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Hyperfine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 26.3% of Hyperfine shares are owned by company insiders. Comparatively, 29.7% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

InspireMD has lower revenue, but higher earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$15.33M	9.55	-$35.57M	-$0.41	N/A
InspireMD	$10.85M	4.30	-$19.92M	-$0.73	N/A

Hyperfine has a beta of 1.38, suggesting that its share price is 38% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

Summary

InspireMD beats Hyperfine on 9 of the 14 factors compared between the two stocks.

Get InspireMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NSPR vs. The Competition

Export

Metric	InspireMD	Surgical & medical instruments Industry	Medical Sector	NYSE Exchange
Market Cap	$46.61M	$45.08M	$6.26B	$23.14B
Dividend Yield	N/A	1.08%	2.69%	4.09%
P/E Ratio	-1.33	17.28	22.42	31.05
Price / Sales	4.30	30.52	548.01	14.78
Price / Cash	N/A	18.87	42.31	24.78
Price / Book	0.54	15.95	9.82	4.68
Net Income	-$19.92M	-$19.55M	$3.56B	$1.07B
7 Day Performance	13.13%	-2.19%	-1.17%	-0.46%
1 Month Performance	-13.48%	-10.26%	3.71%	0.43%
1 Year Performance	-60.98%	-8.04%	27.28%	25.81%

InspireMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
NSPR InspireMD	4.1358 of 5 stars	$1.00 -1.5%	$4.50 +352.3%	-60.2%	$46.61M	$10.85M	N/A	50
INGN Inogen	4.1756 of 5 stars	$6.58 +2.8%	$14.00 +112.8%	-4.2%	$173.28M	$348.67M	N/A	1,030
APYX Apyx Medical	3.0475 of 5 stars	$4.09 -1.0%	$6.50 +58.9%	+137.7%	$172.94M	$52.84M	N/A	270
CVRX CVRx	2.6941 of 5 stars	$6.08 -0.5%	$11.50 +89.1%	-16.2%	$162.13M	$56.65M	N/A	160
EDAP Edap Tms	N/A	$4.31 +0.2%	$6.00 +39.2%	N/A	$161.17M	$70.53M	N/A	230

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NSPR) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InspireMD (NSPR) Competitors